MagicCece123的个人博客分享 http://blog.sciencenet.cn/u/MagicCece123

博文

石胆酸是一种有毒的次级胆汁酸,引起肝内胆汁淤积,具有促肿瘤活性 | MedChemExpress (MCE)

已有 87 次阅读 2024-7-10 10:28 |系统分类:科研笔记

Lithocholic acid

国际站:Lithocholic acid

中文名:石胆酸

CAS:434-13-9

品牌:MedChemExpress (MCE)

存储条件:Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.

生物活性:石胆酸是一种有毒的次级胆汁酸,引起肝内胆汁淤积,具有促肿瘤活性。目标:其他 石胆酸已用于一项研究,以评估胆汁淤积及其对大鼠多种器官和组织的作用。它也被用于一项研究,以研究通过 TGFβ 激活 SMAD3 来调节肝磷脂和胆汁酸稳态。它与人类和实验动物的致癌作用有关。初步体外研究表明,LCA 选择性地杀死神经母细胞瘤细胞,同时保留正常神经元细胞,并且在生理学相关浓度下对许多其他恶性细胞类型具有细胞毒性。

体外:Lithocholic Acid 可抑制 CDCA 和 GW4064 诱导的 FXR 激活,IC50分别为 0.7 和 1.4 μM[5]。Lithocholic Acid (10-30 μM,24 小时) 抑制 HepG2 细胞中 100 nM GW4064 诱导的 BSEP 表达[5]。Lithocholic Acid (0-500 μM) 剂量依赖性地抑制神经母细胞瘤细胞 (BE(2)-m17、SK-n-SH、SK-n-MCIXC 和 Lan-1) 的增殖[3] . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内:Lithocholic acid (补充在饮食中 0.6%,7 天) 会增加雄性小鼠 (C57BL/6) 肝脏中 TGFB1、TGFBR1 和 TGFBR2 mRNA 水平,并激活 SMAD3,并诱导胆道损伤[4].Lithocholic acid (125 mg/kg,腹膜内注射,每天两次,持续四天) 会引起雄性 C57BL/6 小鼠的肝损伤,并增加 AST、ALT 和 ALP 水平[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male mice (C57BL/6)[4]. Dosage: 0.6% LCA-supplement diet, with the AIN93G diet as a control Administration: in diet, for 6 days Result: Induced liver injury. Activated TGFβ-SMAD3 signaling. Increased serum ALP activities. Animal Model: Male mice (C57BL/6)[2]. Dosage: 125 mg/kg, dissolved in corn oil Administration: i.p., twice a day for four days Result: Induced liver injury, generated necrosis and neutrophilic-granulocytic infiltrate (H&E staining). Increased AST, ALT and ALP level.

参考文献:[1]. Jenkins, D.J., et al., Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med, 1993. 329(1): p. 21-6.[2]. Goldberg, A.A., et al., Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget, 2011. 2(10): p. 761-82.[3]. Matsubara, T., et al., TGF-beta-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. J Lipid Res, 2012. 53(12): p. 2698-707.[4]. Yang R, et al. Metabolomic analysis of cholestatic liver damage in mice. Food Chem Toxicol. 2018 Jul 14;120:253-260.[5]. Yu J, et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem. 2002 Aug 30;277(35):31441-7.



https://blog.sciencenet.cn/blog-3536222-1441672.html

上一篇:BW-723C86 是一种有效的选择性 5-HT2B 受体 激动剂 | MedChemExpress (MCE)
下一篇:Lenvatinib mesylate,一种口服多靶点酪氨酸激酶抑制剂 | MedChemExpress (MCE)
收藏 IP: 222.71.56.*| 热度|

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-7-10 15:18

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部